Experimental drug tested for bone health in rare aging disease

This study aims to test the safety and tolerability of an experimental drug called progerinin in adults with Werner syndrome, a rare genetic condition that causes premature aging. Up to five participants will take the drug twice daily for one year to see if it can help slow the loss of bone mineral density, a common problem in this condition. The main goal is to check for side effects, while also looking for early signs of whether the drug affects bone health.